BioSpace News Archive

Transparency Market Research has published a new report on the trocars market. According to the report, the global trocars market was valued at ~US$ 1.3 Bn in 2018.

Curavit Clinical Research, a virtual research organization, and eMoyo USA, LLC, the USA representative of eMoyo, a global leader in healthcare technology, announced a partnership to pave the way for hearing research studies to continue during the COVID-19 pandemic.

Assertio Holdings, Inc., a commercial-stage pharmaceutical company, announced that the company will present at and participate in investor meetings at the Cantor Virtual Global Healthcare Conference.

Enhanced offerings will hold down out-of pocket costs, increase support for chronic health conditions and expand access for underserved communities

Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. and Galmed Pharmaceuticals Ltd. announces that they have entered into a research agreement aiming at combination therapy of ASC41 and Aramchol for the treatment of non-alcoholic steatohepatitis.

Preclinical study at Emory University explores relationship between cellular NAD+ and retinal damage

Ra Medical Systems, Inc., a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will present at the H.C. Wainwright 22nd Annual Global Investment Conference on Wednesday, September 16, 2020 at 1:00 p.m. Eastern time.

Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, announced that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 22nd Annual Global Investment Conference, being held virtually on September 14-16, 2020.

OTC Markets Group Inc., operator of financial markets for 11,000 U.S. and global securities, announced Cogstate Ltd., a cognitive science and technology company publicly listed on the Australian Securities Exchange, has qualified to trade on the OTCQX® Best Market. Cogstate Ltd. upgraded to OTCQX from the Pink® market.

Scientific Advisory Board Member Dr. Joseph F. O’Donnell Steps in as Interim Chief Medical Officer; Jason Summa Joins in Newly Created Clinical Development Role